Ensysce Biosciences Announces Positive Interim Data for Breakthrough Therapy PF614-MPAR

Go back to Ensysce Biosciences Announces Positive Interim Data for Breakthrough Therapy PF614-MPAR
(NASDAQ: ENSC) Delayed: 0.42 -0.02 (4.55%)
Previous Close $0.44    52 Week High $ 
Open $0.44    52 Week Low $ 
Day High $0.44    P/E N/A 
Day Low $0.42    EPS $ 
Volume 108,948